ebook Munafa Stock Market Course + Intraday & FNO calls  

       

CNCE announcements Concert Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Concert Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Concert Pharmaceuticals, Inc. CNCE

Concert Pharmaceuticals, Inc. CNCE listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Concert Pharmaceuticals, Inc. CNCE

Sun Pharma completes acquisition of US-based Concert Pharmaceuticals
Drug major Sun Pharma on Monday said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. The drug major has successfully completed the acquisi
Announcement as on 06 March 2023

Sun Pharma completes acquisition of Concert Pharmaceuticals
The drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company that is developing deuruxolitinib for the potential treatment of adult patients with moderate to severe alopecia area
Announcement as on 06 March 2023

Why Concert Pharmaceuticals Stock Rocketed Higher This Week
What happened If all goes according to plan, Concert Pharmaceuticals (NASDAQ: CNCE) will soon cease to be an independent company. The biotech signed a deal to be acquired by a peer; as a result, its share price leaped more than 17% higher on the week, acco
Announcement as on 20 January 2023

Sun Pharma to acquire US-based Concert Pharmaceuticals for 6 million
Deal size could expand to 7 mn if additional milestone-based payments are made
Announcement as on 19 January 2023

Sun Pharma to acquire US-based Concert Pharmaceuticals for 6 million
Deal size could expand to 7 mn if additional milestone-based payments are made
Announcement as on 19 January 2023

Announcements by Concert Pharmaceuticals, Inc. first page | Next page |

CNCE Concert Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Concert Pharmaceuticals, Inc.

  • 5Day Average: 8.38
  • 12Day Average: 8.38
  • 20Day Average: 8.37
  • 50Day Average: 7.63
  • 100Day Average: 6.35
  • 150Day Average: 6.44
  • 200Day Average: 6.05

CNCE Indicators & signals

Indicator MACD (12,26,9)

8.36, 8.18, 0.25
Indicator MACD is in positive zone

Indicator ADX (14)

6.67, 72.73, 63.64
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 64
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of CNCE Concert Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Fri Mar 2023 8.37 8.35 to 8.55 0.12% 6.76 times
02 Thu Mar 2023 8.36 8.35 to 8.39 -0.36% 2.92 times
01 Wed Mar 2023 8.39 8.37 to 8.39 0.12% 1.37 times
28 Tue Feb 2023 8.38 8.38 to 8.40 -0.24% 0.64 times
27 Mon Feb 2023 8.40 8.38 to 8.41 0.24% 1.07 times
24 Fri Feb 2023 8.38 8.38 to 8.40 -0.12% 0.52 times
23 Thu Feb 2023 8.39 8.39 to 8.41 -0.12% 0.84 times
22 Wed Feb 2023 8.40 8.37 to 8.41 0.6% 0.55 times
21 Tue Feb 2023 8.35 8.34 to 8.41 -0.36% 1.16 times
17 Fri Feb 2023 8.38 8.37 to 8.44 0% 0.46 times
17 Fri Feb 2023 8.38 8.37 to 8.44 0% 0.46 times
16 Thu Feb 2023 8.38 8.35 to 8.41 0.36% 0.98 times

Videos related to: CNCE announcements Concert Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

CNCE announcements Concert Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top